Cranial Nerve III, IV, and VI Palsies in the Cancer Patient

  • Meghan S. Flemmons
  • Jade S. Schiffman
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA, volume 6)


Cranial nerve III, IV, and VI palsies in cancer patients can be caused by primary cranial nerve neoplasms, direct extension from brain, brain stem and skull base tumors, direct extension or perineural spread from head and neck tumors, metastases from tumors at distant sites, leptomeningeal disease, and other conditions, including raised intracranial pressure, radiation effect, infection, paraneoplastic syndromes, and certain medications. Ophthalmologic findings in patients with cranial neuropathies depend on the cranial nerve III, IV and VI involved and the location of involvement. Primary cranial nerve neoplasms are most commonly schwannomas. Skull base tumors often result in cranial nerve involvement as well as primary tumors of the breast, lung, and prostate that metastasize to the skull base. Head and neck cancers travel through the skull base and result in cranial nerve involvement. Leptomeningeal disease is a common cause of deficits of cranial nerves II–VII. Other conditions–from treatment of the primary tumor to complications of chemotherapy and immunosuppression–can result in cranial neuropathies.


Cranial Nerve Skull Base Cavernous Sinus Adenoid Cystic Carcinoma Radiation Necrosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Borges A Casselman J. Imaging the cranial nerves: part II: primary and secondary neoplastic conditions and neurovascular conflicts. Eur Radiol 2007;17(9):2332–44.PubMedCrossRefGoogle Scholar
  2. 2.
    Ayberk G, Ozveren MF, Yildirim T, et al. Review of a series with abducens nerve palsy. Turk Neurosurg 2008;18(4):366–73.PubMedGoogle Scholar
  3. 3.
    St Martin M Levine SC. Chordomas of the skull base: manifestations and management. Curr Opin Otolaryngol Head Neck Surg 2003;11(5):324–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Sethi DS. Isolated sphenoid lesions: diagnosis and management. Otolaryngol Head Neck Surg 1999;120(5):730–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Hall SM Buzdar AU, Blumenschein GR. Cranial nerve palsies in metastatic breast cancer due to osseous metastasis without intracranial involvement. Cancer 1983;53(1):180–4.Google Scholar
  6. 6.
    Ransom DT, Dinapoli RP, Richardson RL. Cranial nerve lesions due to base of the skull metastases in prostate carcinoma. Cancer 1990;65(3):586–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Ginsberg LE. MR imaging of perineural tumor spread. Magn Reson Imaging Clin North Am 2002;10(3):511–25, vi.CrossRefGoogle Scholar
  8. 8.
    Chang JT Lin CY, Chen TM, et al. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy. Int J Radiat Oncol Biol Phys 2005;63(5):1354–60.PubMedCrossRefGoogle Scholar
  9. 9.
    Li JC Mayr NA, Yuh WT, Wang JZ, Jiang GL. Cranial nerve involvement in nasopharyngeal carcinoma: response to radiotherapy and its clinical impact. Ann Otol Rhinol Laryngol 2006;115(5):340–5.PubMedGoogle Scholar
  10. 10.
    Liu L Liang S, Li L, et al. Prognostic impact of magnetic resonance imaging-detected cranial nerve involvement in nasopharyngeal carcinoma. Cancer 2009;115(9):1995–2003.PubMedCrossRefGoogle Scholar
  11. 11.
    Nemec SF Herneth AM, Czerny C. Perineural tumor spread in malignant head and neck tumors. Top Magn Reson Imaging 2007;18(6):467–71.PubMedCrossRefGoogle Scholar
  12. 12.
    Ojiri H. Perineural spread in head and neck malignancies. Radiat Med 2006;24(1):1–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Danesh-Meyer HV, Savino PJ, Sergott RC. Visual loss despite anticoagulation in radiation-induced optic neuropathy. Clin Exp Ophthalmol 2004;32(3):333–5.CrossRefGoogle Scholar
  14. 14.
    Hudgins PA Newman NJ, Dillon WP, Hoffman JC, Jr. Radiation-induced optic neuropathy: characteristic appearances on gadolinium-enhanced MR. AJNR Am J Neuroradiol 1992;13(1):235–8.PubMedGoogle Scholar
  15. 15.
    Tishler RB, Loeffler JS, Lunsford LD, Duma C, Alexander E, 3rd, Kooy HM, Flickinger JC. Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 1993;27(2):215–21.PubMedCrossRefGoogle Scholar
  16. 16.
    Miller NR, Lee AG. Adult-onset acquired oculomotor nerve paresis with cyclic spasms: relationship to ocular neuromyotonia. Am J Ophthalmol 2004;137(1):70–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Ela-Dalman N, Arnold AC, Chang LK, Velez FG, Lasky JL, 3rd. Abducens nerve ocular neuromyotonia following non-sellar or parasellar tumors. Strabismus 2007;15(3):149–51.PubMedCrossRefGoogle Scholar
  18. 18.
    Ko MW, Dalmau J, Galetta SL. Neuro-ophthalmologic manifestations of paraneoplastic syndromes. J Neuroophthalmol 2008;28(1):58–68.PubMedCrossRefGoogle Scholar
  19. 19.
    Schmid KE, Kornek GV, Scheithauer W, Binder S. Update on ocular complications of systemic cancer chemotherapy. Surv Ophthalmol 2006;51(1):19–40.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Ophthalmology and Visual SciencesThe University of Texas Medical BranchGalvestonUSA
  2. 2.Section of Ophthalmology, Department of Head and Neck SurgeryThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations